IBDEI0Q9 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34750,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,34750,1,4,0)
 ;;=4^C82.39
 ;;^UTILITY(U,$J,358.3,34750,2)
 ;;=^5001500
 ;;^UTILITY(U,$J,358.3,34751,0)
 ;;=C82.30^^100^1507^71
 ;;^UTILITY(U,$J,358.3,34751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34751,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Unspec Site
 ;;^UTILITY(U,$J,358.3,34751,1,4,0)
 ;;=4^C82.30
 ;;^UTILITY(U,$J,358.3,34751,2)
 ;;=^5001491
 ;;^UTILITY(U,$J,358.3,34752,0)
 ;;=C82.49^^100^1507^72
 ;;^UTILITY(U,$J,358.3,34752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34752,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,34752,1,4,0)
 ;;=4^C82.49
 ;;^UTILITY(U,$J,358.3,34752,2)
 ;;=^5001510
 ;;^UTILITY(U,$J,358.3,34753,0)
 ;;=C82.40^^100^1507^73
 ;;^UTILITY(U,$J,358.3,34753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34753,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Unspec Site
 ;;^UTILITY(U,$J,358.3,34753,1,4,0)
 ;;=4^C82.40
 ;;^UTILITY(U,$J,358.3,34753,2)
 ;;=^5001501
 ;;^UTILITY(U,$J,358.3,34754,0)
 ;;=C82.99^^100^1507^74
 ;;^UTILITY(U,$J,358.3,34754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34754,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,34754,1,4,0)
 ;;=4^C82.99
 ;;^UTILITY(U,$J,358.3,34754,2)
 ;;=^5001550
 ;;^UTILITY(U,$J,358.3,34755,0)
 ;;=C82.90^^100^1507^75
 ;;^UTILITY(U,$J,358.3,34755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34755,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Unspec Site
 ;;^UTILITY(U,$J,358.3,34755,1,4,0)
 ;;=4^C82.90
 ;;^UTILITY(U,$J,358.3,34755,2)
 ;;=^5001541
 ;;^UTILITY(U,$J,358.3,34756,0)
 ;;=R59.1^^100^1507^60
 ;;^UTILITY(U,$J,358.3,34756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34756,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Generalized
 ;;^UTILITY(U,$J,358.3,34756,1,4,0)
 ;;=4^R59.1
 ;;^UTILITY(U,$J,358.3,34756,2)
 ;;=^5019530
 ;;^UTILITY(U,$J,358.3,34757,0)
 ;;=C91.40^^100^1507^79
 ;;^UTILITY(U,$J,358.3,34757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34757,1,3,0)
 ;;=3^Hairy Cell Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,34757,1,4,0)
 ;;=4^C91.40
 ;;^UTILITY(U,$J,358.3,34757,2)
 ;;=^5001771
 ;;^UTILITY(U,$J,358.3,34758,0)
 ;;=C91.42^^100^1507^77
 ;;^UTILITY(U,$J,358.3,34758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34758,1,3,0)
 ;;=3^Hairy Cell Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,34758,1,4,0)
 ;;=4^C91.42
 ;;^UTILITY(U,$J,358.3,34758,2)
 ;;=^5001773
 ;;^UTILITY(U,$J,358.3,34759,0)
 ;;=C91.41^^100^1507^78
 ;;^UTILITY(U,$J,358.3,34759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34759,1,3,0)
 ;;=3^Hairy Cell Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,34759,1,4,0)
 ;;=4^C91.41
 ;;^UTILITY(U,$J,358.3,34759,2)
 ;;=^5001772
 ;;^UTILITY(U,$J,358.3,34760,0)
 ;;=D57.01^^100^1507^80
 ;;^UTILITY(U,$J,358.3,34760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34760,1,3,0)
 ;;=3^Hb-SS Disease w/ Acute Chest Syndrome
 ;;^UTILITY(U,$J,358.3,34760,1,4,0)
 ;;=4^D57.01
 ;;^UTILITY(U,$J,358.3,34760,2)
 ;;=^5002307
 ;;^UTILITY(U,$J,358.3,34761,0)
 ;;=D57.00^^100^1507^81
 ;;^UTILITY(U,$J,358.3,34761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34761,1,3,0)
 ;;=3^Hb-SS Disease w/ Crisis,Unspec
 ;;^UTILITY(U,$J,358.3,34761,1,4,0)
 ;;=4^D57.00
 ;;^UTILITY(U,$J,358.3,34761,2)
 ;;=^5002306
 ;;^UTILITY(U,$J,358.3,34762,0)
 ;;=D57.02^^100^1507^82
 ;;^UTILITY(U,$J,358.3,34762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34762,1,3,0)
 ;;=3^Hb-SS Disease w/ Splenic Sequestration
 ;;^UTILITY(U,$J,358.3,34762,1,4,0)
 ;;=4^D57.02
 ;;^UTILITY(U,$J,358.3,34762,2)
 ;;=^5002308
 ;;^UTILITY(U,$J,358.3,34763,0)
 ;;=D68.32^^100^1507^84
 ;;^UTILITY(U,$J,358.3,34763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34763,1,3,0)
 ;;=3^Hemorrhagic Disorder d/t Extrinsic Circulating Anticoagulants
 ;;^UTILITY(U,$J,358.3,34763,1,4,0)
 ;;=4^D68.32
 ;;^UTILITY(U,$J,358.3,34763,2)
 ;;=^5002357
 ;;^UTILITY(U,$J,358.3,34764,0)
 ;;=C22.2^^100^1507^85
 ;;^UTILITY(U,$J,358.3,34764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34764,1,3,0)
 ;;=3^Hepatoblastoma
 ;;^UTILITY(U,$J,358.3,34764,1,4,0)
 ;;=4^C22.2
 ;;^UTILITY(U,$J,358.3,34764,2)
 ;;=^5000935
 ;;^UTILITY(U,$J,358.3,34765,0)
 ;;=D58.9^^100^1507^87
 ;;^UTILITY(U,$J,358.3,34765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34765,1,3,0)
 ;;=3^Hereditary Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,34765,1,4,0)
 ;;=4^D58.9
 ;;^UTILITY(U,$J,358.3,34765,2)
 ;;=^5002322
 ;;^UTILITY(U,$J,358.3,34766,0)
 ;;=C81.99^^100^1507^88
 ;;^UTILITY(U,$J,358.3,34766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34766,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,34766,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,34766,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,34767,0)
 ;;=C81.90^^100^1507^89
 ;;^UTILITY(U,$J,358.3,34767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34767,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,34767,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,34767,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,34768,0)
 ;;=D89.2^^100^1507^90
 ;;^UTILITY(U,$J,358.3,34768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34768,1,3,0)
 ;;=3^Hypergammaglobulenemia,Unspec
 ;;^UTILITY(U,$J,358.3,34768,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,34768,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,34769,0)
 ;;=D05.12^^100^1507^91
 ;;^UTILITY(U,$J,358.3,34769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34769,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,34769,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,34769,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,34770,0)
 ;;=D05.11^^100^1507^92
 ;;^UTILITY(U,$J,358.3,34770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34770,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,34770,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,34770,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,34771,0)
 ;;=D05.10^^100^1507^93
 ;;^UTILITY(U,$J,358.3,34771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34771,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,34771,1,4,0)
 ;;=4^D05.10
 ;;^UTILITY(U,$J,358.3,34771,2)
 ;;=^5001929
 ;;^UTILITY(U,$J,358.3,34772,0)
 ;;=D50.0^^100^1507^94
 ;;^UTILITY(U,$J,358.3,34772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34772,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,34772,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,34772,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,34773,0)
 ;;=D50.9^^100^1507^95
 ;;^UTILITY(U,$J,358.3,34773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34773,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,34773,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,34773,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,34774,0)
 ;;=C46.9^^100^1507^96
 ;;^UTILITY(U,$J,358.3,34774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34774,1,3,0)
 ;;=3^Kaposi's Sarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,34774,1,4,0)
 ;;=4^C46.9
 ;;^UTILITY(U,$J,358.3,34774,2)
 ;;=^5001108
 ;;^UTILITY(U,$J,358.3,34775,0)
 ;;=C22.0^^100^1507^97
 ;;^UTILITY(U,$J,358.3,34775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34775,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,34775,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,34775,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,34776,0)
 ;;=D05.02^^100^1507^98
 ;;^UTILITY(U,$J,358.3,34776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34776,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,34776,1,4,0)
 ;;=4^D05.02
 ;;^UTILITY(U,$J,358.3,34776,2)
 ;;=^5001928
 ;;^UTILITY(U,$J,358.3,34777,0)
 ;;=D05.01^^100^1507^99
 ;;^UTILITY(U,$J,358.3,34777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34777,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,34777,1,4,0)
 ;;=4^D05.01
 ;;^UTILITY(U,$J,358.3,34777,2)
 ;;=^5001927
 ;;^UTILITY(U,$J,358.3,34778,0)
 ;;=D05.00^^100^1507^100
 ;;^UTILITY(U,$J,358.3,34778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34778,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,34778,1,4,0)
 ;;=4^D05.00
 ;;^UTILITY(U,$J,358.3,34778,2)
 ;;=^5001926
 ;;^UTILITY(U,$J,358.3,34779,0)
 ;;=R59.0^^100^1507^61
 ;;^UTILITY(U,$J,358.3,34779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34779,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Localized
 ;;^UTILITY(U,$J,358.3,34779,1,4,0)
 ;;=4^R59.0
 ;;^UTILITY(U,$J,358.3,34779,2)
 ;;=^5019529
 ;;^UTILITY(U,$J,358.3,34780,0)
 ;;=C83.59^^100^1507^101
 ;;^UTILITY(U,$J,358.3,34780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34780,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,34780,1,4,0)
 ;;=4^C83.59
 ;;^UTILITY(U,$J,358.3,34780,2)
 ;;=^5001590
 ;;^UTILITY(U,$J,358.3,34781,0)
 ;;=C83.50^^100^1507^102
 ;;^UTILITY(U,$J,358.3,34781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34781,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,34781,1,4,0)
 ;;=4^C83.50
 ;;^UTILITY(U,$J,358.3,34781,2)
 ;;=^5001581
 ;;^UTILITY(U,$J,358.3,34782,0)
 ;;=C43.9^^100^1507^104
 ;;^UTILITY(U,$J,358.3,34782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34782,1,3,0)
 ;;=3^Malig Melanoma of Skin,Unspec Site
 ;;^UTILITY(U,$J,358.3,34782,1,4,0)
 ;;=4^C43.9
 ;;^UTILITY(U,$J,358.3,34782,2)
 ;;=^5001015
 ;;^UTILITY(U,$J,358.3,34783,0)
 ;;=C31.9^^100^1507^105
 ;;^UTILITY(U,$J,358.3,34783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34783,1,3,0)
 ;;=3^Malig Neop Accessory Sinus,Unspec
 ;;^UTILITY(U,$J,358.3,34783,1,4,0)
 ;;=4^C31.9
 ;;^UTILITY(U,$J,358.3,34783,2)
 ;;=^5000953
 ;;^UTILITY(U,$J,358.3,34784,0)
 ;;=C24.1^^100^1507^107
 ;;^UTILITY(U,$J,358.3,34784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34784,1,3,0)
 ;;=3^Malig Neop Ampulla of Vater
 ;;^UTILITY(U,$J,358.3,34784,1,4,0)
 ;;=4^C24.1
 ;;^UTILITY(U,$J,358.3,34784,2)
 ;;=^267100
 ;;^UTILITY(U,$J,358.3,34785,0)
 ;;=C21.0^^100^1507^108
